Cargando…

Low- Versus High-dose Cyclophosphamide in Class III/IV Lupus Nephritis: A Retrospective Study from South Asia

INTRODUCTION: The comparative efficacy of low-dose cyclophosphamide (LD-CYC) and high-dose cyclophosphamide (HD-CYC) for treatment of lupus in South Asians is not well established. We aimed to compare treatment outcomes in South Asian patients with class III and IV lupus nephritis treated with eithe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wijayaratne, Dilushi Rowena, Atukorala, Inoshi Gunetilleke, Gunawardena, Nalika S., Wijesundara, Devasmitha A., Lanerolle, Rushika Dinal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185022/ https://www.ncbi.nlm.nih.gov/pubmed/37197037 http://dx.doi.org/10.4103/ijn.ijn_73_22

Ejemplares similares

Dengue hemorrhagic fever with bleeding and fluid overload in a patient with active lupus nephritis: a case report of diagnostic and therapeutic challenges
por: Vidanapathirana, Manudi, et al.
Publicado: (2023)

Mycophenolate versus Cyclophosphamide for Lupus Nephritis
por: Sahay, M., et al.
Publicado: (2018)

Revisited Cyclophosphamide in the Treatment of Lupus Nephritis
por: Quan, Xiao-ying, et al.
Publicado: (2022)

A potential diagnostic serum immunological marker panel to differentiate between primary and secondary knee osteoarthritis
por: Rankothgedera, Sakuni, et al.
Publicado: (2021)

Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy
por: Nawata, Takashi, et al.
Publicado: (2018)

Multiple ring-enhancing cerebral lesions in systemic lupus erythematosis: a case report
por: Chang, Thashi, et al.
Publicado: (2012)

Effective use of rituximab in combination with low dose cyclophosphamide in childhood onset systemic lupus erythematosus (SLE) with relapsing class IV nephritis
por: Miettunen, PM, et al.
Publicado: (2008)

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy
por: Annavarajula, S. K., et al.
Publicado: (2011)

Final-Year Medical Students’ Perceptions Regarding the Curriculum in Public Health
por: Navinan, Mitrakrishnan Rayno, et al.
Publicado: (2011)

Plasmapheresis for Extrapontine Myelinolysis: A Case Series and a Literature Review
por: Wijesundara, Devasmitha, et al.
Publicado: (2022)

Delay in diagnosis of generalized miliary tuberculosis with osseo-articular involvement: a case report
por: Rodrigo, Chaturaka, et al.
Publicado: (2011)

Rapid and Complete Remission of Class IV Lupus Nephritis with Massive Wire Loop Lesions
por: Suzuki, Tomo, et al.
Publicado: (2018)

Intravenous cyclophosphamide combined with steroids in pediatric onset severe lupus nephritis
por: Vachvanichsanong, Prayong, et al.
Publicado: (2012)

Systematic evaluation of different doses of cyclophosphamide induction therapy for lupus nephritis
por: Tian, Ming, et al.
Publicado: (2017)

Mycophenolate or Cyclophosphamide in Lupus Nephritis: Which One to Use in Indian Patients?
por: Rathi, Manish, et al.
Publicado: (2018)

Profiling analysis of circulating microRNA in peripheral blood of patients with class IV lupus nephritis
por: Navarro-Quiroz, Elkin, et al.
Publicado: (2017)

Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide
por: Audemard-Verger, Alexandra, et al.
Publicado: (2016)

Cyclophosphamide Attenuates Fibrosis in Lupus Nephritis by Regulating Mesangial Cell Cycle Progression
por: Ma, Yuehong, et al.
Publicado: (2021)

suPAR and WT1 modify the adhesion of podocytes and are related to proteinuria in class IV lupus nephritis
por: Bollain-y-Goytia, Juan-José, et al.
Publicado: (2023)

A diagnostic conundrum; Kimura’s disease mimicking eosinophilic granulomatosis with polyangiitis
por: Aravinthan, Mythily, et al.
Publicado: (2022)

Early achievement of deep remission predicts low incidence of renal flare in lupus nephritis class III or IV
por: Hanaoka, Hironari, et al.
Publicado: (2018)

Comparison urine neutrophil gelatinase - associated lipocalin with standard parameters in monitoring activity Lupus nephritis: Class IV
por: Rabrenović, Violeta, et al.
Publicado: (2023)

Relation of peritubular capillary features to class of lupus nephritis
por: Anutrakulchai, Sirirat, et al.
Publicado: (2016)

Acromegaly presenting with low insulin-like growth factor-1 levels and diabetes: a case report
por: Wijayaratne, Dilushi Rowena, et al.
Publicado: (2015)

Class IV Lupus Nephritis in the Setting of Serologically Quiescent Disease and Normal Urine Sediment in a Patient with Late-Onset Systemic Lupus Erythematosus
por: Nnodum, Benedicta, et al.
Publicado: (2019)

O19 A Complex Case of Systemic Lupus Erythematosus with Class IV Lupus Nephritis in a 15-year-old Egyptian Girl
por: Malik, Dr Saadia, et al.
Publicado: (2020)

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
por: Atisha‐Fregoso, Yemil, et al.
Publicado: (2020)

Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review
por: Margiotta, Domenico Paolo Emanuele, et al.
Publicado: (2018)

The ISN/RPS 2016 classification predicts renal prognosis in patients with first-onset class III/IV lupus nephritis
por: Hachiya, Asaka, et al.
Publicado: (2021)

Endocapillary hypercellularity levels are associated with early complete remission in children with class IV lupus nephritis as the initial presentation of SLE
por: Li, Chunzhen, et al.
Publicado: (2022)

Expression of CMIP in podocytes is restricted to specific classes of lupus nephritis
por: Bouachi, Khedidja, et al.
Publicado: (2018)

Serum CA125 a potential marker of volume status for peritoneal dialysis patients?
por: Wijayaratne, Dilushi, et al.
Publicado: (2021)

Star fruit nephrotoxicity: a case series and literature review
por: Wijayaratne, Dilushi Rowena, et al.
Publicado: (2018)

Outcome of low dose cyclophosphamide for induction phase treatment of lupus nephritis, a single center study
por: Sigdel, Mahesh R., et al.
Publicado: (2016)

31 De Novo Class IV+V Lupus Nephritis After the BNT162b2 COVID-19 Vaccine
Publicado: (2022)

A field tool for prediction of body fat in Sri Lankan women: skinfold thickness equation
por: Waidyatilaka, Indu, et al.
Publicado: (2016)

Outcomes of COVID-19 in Kidney Transplant Recipients: The Sri Lankan Experience
por: Wijayaratne, Dilushi, et al.
Publicado: (2023)

The long-term outcomes and histological transformation in class II lupus nephritis
por: Alsuwaida, Abdulkareem O., et al.
Publicado: (2018)

Immune gene expression and functional networks in distinct lupus nephritis classes
por: Gilmore, Alyssa C, et al.
Publicado: (2022)

Dan Bai Xiao Formula combined with glucocorticoids and cyclophosphamide for pediatric lupus nephritis: A pilot prospective study
por: Cao, Tong-Tong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qs9v2muc3nbk210j8v13t4gjme